Literature DB >> 7528258

Calcium-binding properties of fetuin in fetal bovine serum.

M Suzuki1, H Shimokawa, Y Takagi, S Sasaki.   

Abstract

Fetuin, an abundant protein in fetal bovine plasma, is the bovine homolog of human alpha 2HS glycoprotein (alpha 2HS). In spite of numerous studies, the biological functions of both proteins remain elusive. We now report the remarkable 45Ca-binding activity of fetuin in fetal bovine serum that has been blotted on a membrane after electrophoresis. The Ca-binding ability of the purified protein was analyzed by equilibrium dialysis, which revealed that bovine fetuin had multiple Ca-binding sites, one of which had a Kd of 0.95 x 10(-4) M. It was also shown that the Ca-binding activity of fetuin was greater than that of albumin in serum of the bovine fetus at the late gestational stage. Since fetal bovine serum contains not only a high concentration of fetuin but also a high concentration of Ca, it is possible that fetuin functions to maintain high levels of Ca in fetal serum via normalization of the concentration of Ca2+ ions.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7528258     DOI: 10.1002/jez.1402700603

Source DB:  PubMed          Journal:  J Exp Zool        ISSN: 0022-104X


  14 in total

1.  Critical evaluation of gamma-irradiated serum used as feeder in the culture and demonstration of putative nanobacteria and calcifying nanoparticles.

Authors:  Jan Martel; Cheng-Yeu Wu; John D Young
Journal:  PLoS One       Date:  2010-04-26       Impact factor: 3.240

2.  Peripheral administration of fetuin-A attenuates early cerebral ischemic injury in rats.

Authors:  Haichao Wang; Wei Li; Shu Zhu; Jianhua Li; Jason D'Amore; Mary F Ward; Huan Yang; Rongqian Wu; Willi Jahnen-Dechent; Kevin J Tracey; Ping Wang; Andrew E Sama
Journal:  J Cereb Blood Flow Metab       Date:  2009-12-02       Impact factor: 6.200

3.  Regulatory inhibition of biological tissue mineralization by calcium phosphate through post-nucleation shielding by fetuin-A.

Authors:  Joshua C Chang; Robert M Miura
Journal:  J Chem Phys       Date:  2016-04-21       Impact factor: 3.488

4.  Association of alpha2-HS glycoprotein (AHSG, fetuin-A) polymorphism with AHSG and phosphate serum levels.

Authors:  Motoki Osawa; Wei Tian; Hidekazu Horiuchi; Mika Kaneko; Kazuo Umetsu
Journal:  Hum Genet       Date:  2004-12-09       Impact factor: 4.132

5.  Fetuin-A is a mineral carrier protein: small angle neutron scattering provides new insight on Fetuin-A controlled calcification inhibition.

Authors:  Alexander Heiss; Vitaliy Pipich; Willi Jahnen-Dechent; Dietmar Schwahn
Journal:  Biophys J       Date:  2010-12-15       Impact factor: 4.033

6.  Hyperphosphatemia-induced nanocrystals upregulate the expression of bone morphogenetic protein-2 and osteopontin genes in mouse smooth muscle cells in vitro.

Authors:  Andrew P Sage; Jinxiu Lu; Yin Tintut; Linda L Demer
Journal:  Kidney Int       Date:  2010-10-13       Impact factor: 10.612

7.  Fetuin-A/albumin-mineral complexes resembling serum calcium granules and putative nanobacteria: demonstration of a dual inhibition-seeding concept.

Authors:  Cheng-Yeu Wu; Jan Martel; David Young; John D Young
Journal:  PLoS One       Date:  2009-11-30       Impact factor: 3.240

8.  Imparting bone affinity to glycoproteins through the conjugation of bisphosphonates.

Authors:  Sébastien A Gittens; John R Matyas; Ronald F Zernicke; Hasan Uludağ
Journal:  Pharm Res       Date:  2003-07       Impact factor: 4.200

9.  Putative nanobacteria represent physiological remnants and culture by-products of normal calcium homeostasis.

Authors:  John D Young; Jan Martel; Lena Young; Cheng-Yeu Wu; Andrew Young; David Young
Journal:  PLoS One       Date:  2009-02-09       Impact factor: 3.240

10.  A hepatic protein, fetuin-A, occupies a protective role in lethal systemic inflammation.

Authors:  Wei Li; Shu Zhu; Jianhua Li; Yan Huang; Rongrong Zhou; Xuegong Fan; Huan Yang; Xing Gong; N Tony Eissa; Willi Jahnen-Dechent; Ping Wang; Kevin J Tracey; Andrew E Sama; Haichao Wang
Journal:  PLoS One       Date:  2011-02-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.